Volitionrx ltd (VNRX)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Operating Activities
Net Loss

-16,099

-18,008

-14,769

-11,905

-9,530

-8,213

-3,710

-4,083

-2,608

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

676

636

528

309

236

142

146

135

118

Amortization of operating lease right-of-use assets

225

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-

0

38

3

0

-

-

-

-

Impairment of intangible asset

-

-

-

-

-

-

350

0

-

Stock based compensation

1,458

2,570

2,435

1,678

1,493

767

282

858

407

Non-operating income - grants received

-

-

-

-

146

-

-

-

-

Warrants issued for services

-

-

-

-

-

708

472

432

362

Warrants issued for services

8

22

-

-

-

-

-

-

-

Warrants issued for services

-

-

54

164

-42

-

-

-

-

Financing costs for warrants modified

196

-

-

-

-

-

-

-

-

Amortization of stock issued in advance of services

-

-

-

-

-

-

250

70

29

Non-operating income  grants received

-

-

-

-

-

-143

-865

0

-

Gain on derivative re-measurement

-

-

-

-

-339

1,424

0

-

-

Derivative expense

-

-

-

-

-

995

0

-

-

Changes in operating assets and liabilities:
Deferred grant income

-

-

-

-

48

-

-

-

-

Prepaid expenses

-22

10

-82

-13

-12

-78

-50

-25

0

Deferred grant income

-

-

-50

-170

-

-

-

-

-

Other current assets

-92

-29

-7

-22

-108

-24

5

-7

-14

Accounts payable and accrued liabilities

1,105

100

-339

1,090

-95

281

34

305

53

Management and directors' fees payable

20

-34

-

-

-

-

-

-

-

Operating leases liabilities

-217

-

-

-

-

-

-

-

-

Net Cash Used In Operating Activities

-12,739

-14,733

-12,193

-8,864

-8,546

-4,140

-3,084

-2,314

-1,652

Investing Activities:
Purchases of property and equipment

-511

-301

1,425

415

77

302

0

90

34

Purchase of patents

-

-

-

-

55

0

-

-

-

Net Cash Used In Investing Activities

-511

-301

-1,425

-415

-132

-302

-0

-90

-34

Financing Activities:
Net proceeds from issuances of common shares

16,591

17,245

998

25,302

12,497

5,626

2,828

2,576

1,595

Payments on long-term debt

-

-

52

-

-

-

-

-

-

Proceeds from grants repayable

32

177

-

-

-

-

-

-

-

Proceeds from grants repayable

-

-

-

-

146

-

-

-

-

Proceeds from grants received

-

-

-

-

-

143

819

0

-

Proceeds from long-term debt

838

1,159

1,201

-

-

-

-

-

-

Payments on long-term debt

-351

-436

-

-

-

-

-

-

-

Payments on grants repayable

-39

-40

-

-

-

-

-

-

-

Grants received

-

-

-

-

-

-

-

-

676

Proceeds from debt payable

-

-

-

474

0

-

-

0

0

Payments on grants repayable

-

-

45

-

-

-

-

-

-

Grants repaid

-

-

-

36

33

-33

0

-

-

Loans repaid

-

-

-

0

-

-

-

-

-

Payments on financing leases

-142

-137

135

552

-

-

-

-

-

Deferred grant income

-

-

-

-

-

0

-

-

-

Payments on capital lease obligations

-

-

-

-

-216

0

-

-

-

Repayment of note payable

-

-

-

-

-

-

54

102

289

Cash acquired through reverse merger

-

-

-

-

-

-

-

0

0

Net Cash (Used In) Provided By Financing Activities

16,929

17,967

1,966

25,188

12,442

5,737

3,593

2,473

1,982

Effect of foreign exchange on cash and cash equivalents

-139

378

89

-145

13

-43

3

-40

4

Net Change in Cash and Cash Equivalents

3,538

3,310

-11,562

15,762

3,777

1,250

512

28

300

Supplemental Disclosures of Cash Flow Information:
Interest paid

-

-

73

-

-

-

-

-

-

Interest paid

126

110

-

20

7

10

0

0

0

Non-Cash Financing Activities:
Income tax paid

-

-

-

0

0

0

0

0

0

Non - Cash Financing Activities:
Common Stock issued on cashless exercises of stock options and warrants

0

0

-

-

-

-

-

-

-

Finance lease obligations

-

28

-

-

-

-

-

-

-

Reduction in derivative liability

-

-

-

-

1,237

-

-

-

-

Common Stock issued on cashless exercises of stock options

-

-

-

-

-

0

-

-

-

Acquisition of subsidiary for debt

-

-

-

-

-

-

-

0

0

Common stock issued for debt

-

-

-

-

-

-

0

0

1,169

Common stock issued on cashless exercises of stock options

-

-

0

0

0

-

-

-

-

Offering costs from issuance of common stock

-

872

-

-

-

-

-

-

-

Change in derivative liability

-

-

-

-

-

3,924

0

-

-

Capital lease obligation for equipment purchases

-

-

-

1,008

381

0

-

-

-